反応式
[CH3:1][O:2][C:3]1[C:4]([CH3:15])=[N:5][CH:6]=[CH:7][C:8]=1[N:9]1[CH2:14][CH2:13][NH:12][CH2:11][CH2:10]1.C(N(CC)CC)C.[CH3:23][CH:24]([CH3:30])/[CH:25]=[CH:26]/[C:27](Cl)=[O:28]>ClCCl>[CH3:1][O:2][C:3]1[C:4]([CH3:15])=[N:5][CH:6]=[CH:7][C:8]=1[N:9]1[CH2:10][CH2:11][N:12]([C:27](=[O:28])/[CH:26]=[CH:25]/[CH:24]([CH3:30])[CH3:23])[CH2:13][CH2:14]1参加物
5
実験手順
1-(3-Methoxy-2-methyl-4-pyridyl)piperazine (20.7 mg, 0.1 mmol) was dissolved in dichloromethane (1 ml), triethylamine was added (1 ml of a 0.12 M solution in dichloromethane) followed by a solution of (E)-4-methylpent-2-enoyl chloride (1 ml, 0.12 M in dichloromethane). The mixture was shaken briefly, washed with 5% sodium bicarbonate solution (2×), water and evaporated to dryness. The raw product was purified by preparative HPLC (gradient of water containing 0.1% ammonia and acetonitrile) to yield 2.2 mg of a solid (0.007 mmol, 7%).
後処理
- washwashed with 5% sodium bicarbonate solution (2×), water
- customevaporated to dryness
- customThe raw product was purified by preparative HPLC (gradient of water containing 0.1% ammonia and acetonitrile)
出典と根拠
- ORDレコード
- ord-ca634ec73b514dff8534f717029a5b91
- 出典データセット
- uspto-grants-2014_11
- 特許番号
- US08883791B2
関連ノート
読み込み中…